Evaluation of the bioavailability of 1H-imidazole-4,5-dicarboxylic acid derivatives using the calculated and experimental lipophilicity index of the molecule logP

Victor V. Iljin , Elena V. Litasova , Maksim S. Kvasov , Mariia A. Brusina , Levon B. Piotrovskiy

Reviews on Clinical Pharmacology and Drug Therapy ›› 2022, Vol. 20 ›› Issue (1) : 55 -60.

PDF
Reviews on Clinical Pharmacology and Drug Therapy ›› 2022, Vol. 20 ›› Issue (1) : 55 -60. DOI: 10.17816/RCF20155-60
Original study articles
research-article

Evaluation of the bioavailability of 1H-imidazole-4,5-dicarboxylic acid derivatives using the calculated and experimental lipophilicity index of the molecule logP

Author information +
History +
PDF

Abstract

BACKGROUND: It is important to know the ability of a substance to penetrate the cell membrane to assess the bioavailability of drugs. The distribution of matter between the organic phase and water can be used as a model of the distribution between the membrane and extracellular fluid, and can be expressed by a partion coefficient, called logP.

AIM: The aim of this work was to determine the logP of 1H-imidazole-4,5-dicarboxylic acid (IDC) derivatives in various media and compare the values with theoretical ones.

RESULTS: As a result of the work, the distribution coefficients of the IDC derivatives were determined from the optical density data for a fixed wavelength of 250 nm (without a buffer). The distribution coefficients of the IDC derivatives over the maxima of the UV spectra (in the buffer) were determined. A comparison of theoretical and experimental values of the distribution coefficients of some IDC derivatives is carried out.

CONCLUSION: Thus, it has been shown that for a more accurate assessment of the bioavailability of drugs, it is not enough to rely only on the calculated logP index, it is necessary to conduct an experimental test, or introduce some correction factors to recalculate the theoretical logP index, in each specific class of compounds.

Keywords

1H-imidazole-4,5-dicarboxylic acid / logP / bioavailability of drugs

Cite this article

Download citation ▾
Victor V. Iljin, Elena V. Litasova, Maksim S. Kvasov, Mariia A. Brusina, Levon B. Piotrovskiy. Evaluation of the bioavailability of 1H-imidazole-4,5-dicarboxylic acid derivatives using the calculated and experimental lipophilicity index of the molecule logP. Reviews on Clinical Pharmacology and Drug Therapy, 2022, 20(1): 55-60 DOI:10.17816/RCF20155-60

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Potapkin AM, Lebedev AA, Bychkov ER, et al. Study of anticonvulsant properties of new antagonists of glutamate receptors. Reviews on Clinical Pharmacology and Drug Therapy. 2015. Vol. 13, No. 2. P. 3–9. (In Russ.) DOI: 10.17816/RCF1323-9

[2]

Потапкин А.М., Лебедев А.А., Бычков Е.Р., и др. Исследование противосудорожных свойств новых антагонистов глутаматных рецепторов // Обзоры по клинической фармакологии и лекарственной терапии. 2015. Т. 13, № 2. С. 3–9. DOI: 10.17816/RCF1323-9

[3]

Yakovleva EE, Bychkov ER, Brusina MA, et al. Pharmacological activity of new imidazole-4,5-dicarboxylic acid derivatives in dopaminergic transmission suppression tests in mice and rats. Research Results in Pharmacology. 2020;6(4):51–57. (In Russ.) DOI: 10.3897/rrpharmacology.6.57883

[4]

Yakovleva E.E., Bychkov E.R., Brusina M.A., et al. Pharmacological activity of new imidazole-4,5-dicarboxylic acid derivatives in dopaminergic transmission suppression tests in mice and rats // Research Results in Pharmacology. 2020. Vol. 6, No. 4. P. 51–57. DOI: 10.3897/rrpharmacology.6.57883

[5]

Jakovleva EE, Foksha SP, Brusina MA, et al. Studying the anticonvulsive activity of new ligands of NDMA-receptor complex – imidazole-4,5-dicarbonic acid derivatives. Research Results in Pharmacology. 2020;18(2):149–154. (In Russ.) DOI: 10.17816/RCF182149-154

[6]

Яковлева Е.Е., Фокша С.П., Брусина М.А., и др. Исследование противосудорожной активности новых лигандов NMDA-рецепторного комплекса — производных имидазол-4,5-дикарбоновых кислот // Обзоры по клинической фармакологии и лекарственной терапии. 2020. Т. 18, № 2. С. 149–154. DOI: 10.17816/RCF182149-154

[7]

Dergachev VD, Yakovleva EE, Brusina MA, et al. Antiparkinsonian activity of new N-methyl-D-aspartate receptor ligands in the arecoline hyperkinesis test. Medical Council. 2021;12:406–412. (In Russ.) DOI: 10.21518/2079-701X-2021-12-406-412

[8]

Дергачев В.Д., Яковлева Е.Е., Брусина М.А., и др. Противопаркинсоническая активность новых лигандов N-метил-D-аспартат-рецепторов в тесте ареколинового гиперкинеза // Медицинский Совет. 2021. T. 12. С. 406–412. DOI: 10.21518/2079-701X-2021-12-406-412

[9]

GOST 32291-2013. Testing of chemicals of environmental hazard. Determination of partition coefficient (n-octanol/water) by slow-stirring method. Moscow: Standartinform; 2014. (In Russ.) Available from: https://docs.cntd.ru/document/1200108296?section= status

[10]

ГОСТ 32291-2013. Методы испытаний химической продукции, представляющей опасность для окружающей среды. Определение коэффициента распределения н-октанол/вода методом медленного перемешивания. Москва: Стандартинформ, 2014. Режим доступа: https://docs.cntd.ru/document/1200108296?section=status. Дата обращения: 21.03.2022.

RIGHTS & PERMISSIONS

Iljin V.V., Litasova E.V., Kvasov M.S., Brusina M.A., Piotrovskiy L.B.

AI Summary AI Mindmap
PDF

151

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/